- ¥280 - 4490
- Solarbio
- IP3650
- 北京
- 2026年08月13日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
相关阅读
从原料到标记，打造属于中国自己的流式抗体品牌推荐！临床医学研究优质期刊，覆盖29个领域五大应用案例：Mustang Q 膜层析应用全解析1 个小工具，一次性搞定流程图、质粒图谱和信号通路图- 详细信息
- 文献和实验
- 技术资料
- 库存：
999
- 英文名：
PF-8380
- CAS号：
1144035-53-9
- 保质期：
Powder:2-8℃，2 years;Insolvent(母液):-20℃，6 months;-80℃，1 year
- 供应商：
北京索莱宝科技有限公司
- 保存条件：
Powder:2-8℃，2 years;Insolvent(母液):-20℃，6 months;-80℃，1 year
- 规格：
5mg/10mg/100mg/50mg/25mg/1mg
| 规格： | 5mg | 产品价格： | ¥490.00 |
|---|---|---|---|
| 规格： | 10mg | 产品价格： | ¥790.00 |
| 规格： | 100mg | 产品价格： | ¥4490.00 |
| 规格： | 50mg | 产品价格： | ¥2790.00 |
| 规格： | 25mg | 产品价格： | ¥1690.00 |
| 规格： | 1mg | 产品价格： | ¥280.00 |
| CAS | 1144035-53-9 |
| 英文名称 | PF-8380 |
| 分子式 | C22H21Cl2N3O5 |
| 分子量 | 478.33 |
| 规格 | 1mg ; 5mg ; 10mg ; 25mg ; 50mg ; 100mg |
| 溶解性 | Soluble in DMSO ≥5mg/mL |
| 纯度 | ≥98% |
| 外观(性状) | Off-white to brown Solid |
| 储存条件 | Powder:2-8℃，2 years;Insolvent(母液):-20℃，6 months;-80℃，1 year |
| 运输条件 | 冷藏运输 |
| MDL | MFCD20527274 |
| SMILES | O=C(N1CCN(CCC(C2=CC=C3NC(OC3=C2)=O)=O)CC1)OCC4=CC(Cl)=CC(Cl)=C4 |
| InChIKey | JMSUDQYHPSNBSN-UHFFFAOYSA-N |
| InChI | InChI=1S/C22H21Cl2N3O5/c23-16-9-14(10-17(24)12-16)13-31-22(30)27-7-5-26(6-8-27)4-3-19(28)15-1-2-18-20(11-15)32-21(29)25-18/h1-2，9-12H，3-8，13H2，(H，25，29) |
| PubChem CID | 25265312 |
| 靶点 | Phosphodiesterase (PDE) |
| 通路 | Metabolic Enzyme&Protease |
| 背景说明 | PF-8380是一种新型、有效和特异性的自分泌运动因子 (ATX) 抑制剂。 |
| 生物活性 | PF-8380 is a potent autotaxin inhibitor with an IC50 of 2.8 nM in isolated enzyme assay and 101 nM in human whole blood.[1-3] |
| In Vitro | PF-8380 also inhibits rat autotaxin with an IC50 of 1.16 nM with FS-3 substrate. Potency of PF-8380 is maintained when using enzyme produced from fetal fibroblasts used in combination with lysophosphatidyl choline (LPC) as a substrate. In human whole blood incubated with PF-8380 for 2 h， autotaxin is inhibited with an IC50 of 101 nM[1]. Autotaxin (ATX)， an enzyme with lysophospholipase D (lysoPLD) activity， catalyzes the production of lysophosphatidic acid (LPA) from lysophosphatidylcholine (LPC). Pre-treatment of GL261 and U87-MG cells with 1 μM PF-8380 followed by 4 Gy irradiation results in decreased clonogenic survival， decreases migration (33% in GL261; P=0.002 and 17.9% in U87-MG; P=0.012)， decreases invasion (35.6% in GL261; P=0.0037 and 31.8% in U87-MG; P=0.002)， and attenuates radiation-induced Akt phosphorylation[2]. |
| In Vivo | The pharmacokinetic profile of PF-8380 is evaluated at an intravenous dose of 1 mg/kg and oral doses of 1 to 100 mg/kg out to 24 h. PF-8380 has mean clearance of 31 mL/min/kg， volume of distribution at steady state of 3.2 L/kg， and effective t1/2 of 1.2 h. Oral bioavailability is moderate， ranging from 43 to 83%. Plasma concentrations increased with single oral escalating doses， but Cmax increased at a rate that is approximately proportional to dose from 1 to 10 mg/kg and less than proportional to dose from 10 to 100 mg/kg. PF-8380 exposures estimated by area under the curve are approximately proportional to dose and linear up to 100 mg/kg. Plasma C16:0， C18:0， and C20:0 LPA levels are measured immediately after collection. Maximal reduction of LPA levels is observed by the 3 mg/kg dose at 0.5 h with all LPA returning at or above baseline at 24 h[1]. Treatment with 10 mg/kg PF-8380 increases tumor-associated vascularity modestly by 20% (P=0.497). When compared to control， treatment of PF-8380 45 min before 4 Gy irradiation decreases vascularity by nearly 48% when compared to control (P=0.031) and by 65% when compared to mice that received radiation alone (P=0.011)[2]. |
| 细胞实验 | HUVEC (1×106) and bEnd.3 cells (1×106) are plated in 100 mm plates and after 24 h， U87-MG (2×106) and GL261 (2×106) cells are plated onto transwell inserts. After co-culture for 24 h， cells are treated with 1 μM of PF-8380 or vehicle control DMSO for 45 min prior to irradiation with 0， 2， 4， 6， or 8 Gy. After the treatments as co-culture with either PF-8380 or DMSO calculated numbers of U87-MG and GL261 cells are plated to enable normalization for plating efficiencies. After 7 to 10 day incubation plates are fixed with 70% EtOH and stained with 1% methylene blue. Colonies consisting of >50 cells are counted by viewing the plates under a microscope. The survival fractions are calculated as (number of colonies/number of cells plated)/(number of colonies for corresponding control/number of cells plated). Survival curves are analyzed by curve fitting to the alpha/beta model calculating D0 and n[2]. |
| 动物实验 | Rats[1]Male Lewis rats weighing 275 to 300 g are used and acclimated to their surroundings for approximately 1 week with food and water provided ad libitum. A minimum of 1 day before study， animals are anesthetized with isoflurane (to effect) and implanted with Culex vascular catheters in the carotid artery. Animals are acclimated in Culex cages overnight before dosing. Patency of the carotid artery catheter is maintained by using the "tend" function of the Culex automated blood sampler. Animals are dosed with PF-8380 at 1， 3， 10， 30， and 100 mg/kg by oral gavage after an overnight fast. Blood collections are obtained from the carotid artery and performed by the Culex automated blood sampler at 0.25， 0.5， 1， 2， 4， 6， 8， and 24 h after administration. Blood is centrifuged， and plasma is collected for analysis of PF-8380 and LPA concentrations.Mice[2] GL261 cells (1×106) are injected into the right hind limb of nude mice. Once tumors are palpable the mice are serpentine sorted into groups of six to seven animals representing similar distributions of tumor sizes (range=240 mm3). Tumor bearing mice are injected intraperitoneally with vehicle (DMSO) or PF-8380 at 10 mg/kg body weight once daily for five consecutive days. Forty five minutes after drug injection， mice are anesthetized with isoflurane and positioned in the RS2000 irradiator. They are then irradiated with 2 Gy daily for five consecutive days for a total of 10 Gy. Lead blocks (10 mm thick) are used to shield the head， thorax， and abdomen. Tumor size is monitored longitudinally using an external traceable digital caliper. Mice are sacrificed by cervical dislocation once the tumors reached a volume of approximately 10 mm3 or when ulceration becomes apparent. |
| 激酶实验 | FS-3 substrate is solubilized in assay buffer at 500 μM and frozen at -20°C in single-use aliquots for up to 4 weeks. Recombinant autotaxin is diluted in Tris-buffered saline (140 mM NaCl， 5 mM KCl， 1 mM CaCl2， 1 mM MgCl2， 50 mM Tris， pH 8.0) and incubated with compound in DMSO or DMSO alone (final 1% DMSO) for 15 min at 37°C， and the reaction is started with the addition of FS-3 at a final concentration of 1 μM. The reaction is allowed to proceed at 37°C for 30 min and monitored at 520 nm until the uninhibited control compared with a no-enzyme control gave a Z′≥0.5. IC50s are determined in triplicate by using a four-parameter fit[1]. |
| 数据来源文献 | [1]. Gierse J， et al. A novel autotaxin inhibitor reduces lysophosphatidic acid levels in plasma and the site of inflammation. J Pharmacol Exp Ther. 2010 Jul;334(1):310-7. [2]. Bhave SR， et al. Autotaxin Inhibition with PF-8380 Enhances the Radiosensitivity of Human and Murine Glioblastoma Cell Lines. Front Oncol. 2013 Sep 17;3:236. [3]. Cao P， et al. Autocrine lysophosphatidic acid signaling activates β-catenin and promotes lung allograft fibrosis. J Clin Invest. 2017 Apr 3;127(4):1517-1530. |
| 单位 | 瓶 |
| 表格1 | |*|1mg|5mg|10mg|$$|1mM|2.0906mL|10.453mL|20.9061mL|$$|5mM|0.4181mL|2.0906mL|4.1812mL|$$|10mM|0.2091mL|1.0453mL|2.0906mL| |
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验相关实验
用张力计等测定。以水柱的长度（单位：厘米）表示土壤对水的吸力即基质势时，数字的幅度过大，因此 R． K． Schofield取其对数以 PF表示之。 100厘米的水柱相当于 100克 /平方厘米的压力， PF=2，永久凋萎点约相当于 15个大气压， PF=4.2。
血小板因子Ⅲ（PF3）有效性测定 【参考范围】被检者血浆与正常富含血小板血浆（PRP）及乏血小板血浆（PPP）分别反应，后者较前者凝血时间（检测器法）延长不超过5s.【影响因素】1.最好采用硅化或塑料注射器，玻璃试管等需涂硅处理或使用塑料制品。因为玻璃可以激活凝血反应。 2.较理想的抗凝剂应首选枸橼酸钠。 3.止血带不应扎得太紧，时间最好不超过5min，医学教|育网搜集整理并强调采血顺利，以防激活凝血反应。 4.PF3有效测定的准确性取决于富含
上海西唐生物科技有限公司 021-55229872, 65333639 www.westang.com 人血小板因子-4 ( PF-4 )ELISA 试剂盒 ( 用于血清、血浆、细胞培养上清液和其它生物体液内 ) 原理 本实验采用双抗体夹心 ABC-ELISA 法。用抗人 Platelet Factor 4 单抗包被于酶标板上，标准品和样品中的 PF-4与单抗结合，加入生物
PF-8380
¥280 - 4490
